Ovid Therapeutics Inc. (OVID)
NASDAQ · Manufacturing · Pharmaceutical preparations
$2.41−$0.0849 (−3.40%) on the dayAs of the close; data may be delayed.
OVID price, last 12 months
Key stats
- Previous close
- $2.50
- Open
- $2.54
- Day range
- $2.40 – $2.54
- 52-week range
- $1.18 – $3.11
- Volume
- 1.2M
- Avg volume (20 days)
- 1.8M
- Market cap
- $468.7M
Performance
1W−10.4%
1M−16.3%
3M−5.5%
6M−2.0%
YTD+47.9%
1Y+72.2%
vs S&P 500, 1Y+55.4 pts
Technicals and fundamentals
About Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $468.7M